Abstract
In January 2021, the UK joined Project Orbis, a multi-nation programme coordinated by the FDA that provides a framework for concurrent submission and review of innovative oncology products to deliver faster patient access. This research evaluates all medicines approved by the MHRA under Project Orbis compared to EU, and how these were reimbursed in England by NICE and NHSE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
